Patrick D. Spangler

Companies

• OptimizeRx CorpBoard member Mar 29, 2018 to now¹
• OptimizeRx CorpSVP of Product & Strategy Mar 29, 2018 to Mar 29, 2018¹
• EpocratesChief financial officer Feb 1, 2011 to Jan 24, 2012²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OOptimizeRx Corp OPRX78,732 shares³$694.4K at $8.82Jun 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 9, 2026Granted 34,517 shares of OptimizeRx Corp³
• Aug 28, 2025Sold 11,120 shares at $17.49 of OptimizeRx Corp⁴
• Jun 11, 2025Granted 9,868 shares of OptimizeRx Corp⁵
• Jun 7, 2024Granted 13,286 shares of OptimizeRx Corp⁶
• Jun 5, 2024Exercised options 10,061 shares of OptimizeRx Corp⁶
• Jun 7, 2023Exercised options 4,637 shares of OptimizeRx Corp⁷
• Mar 31, 2023Exercised options 657 shares of OptimizeRx Corp⁸
• Dec 30, 2022Exercised options 409 shares of OptimizeRx Corp⁹
• Sep 29, 2022Exercised options 334 shares of OptimizeRx Corp¹⁰
• Nov 11, 2021Sold 6,252 shares at $84.38 of OptimizeRx Corp¹¹